Mia's Feed
Medical News & Research

Innovative Exploding Capsule Technology Enables Needle-Free Insulin Delivery Using Sodium Bicarbonate

Innovative Exploding Capsule Technology Enables Needle-Free Insulin Delivery Using Sodium Bicarbonate

Share this article

Georgia Tech researchers have created a pioneering capsule that delivers insulin and other biologics orally without injections by using a simple chemical reaction to generate internal pressure, offering a less invasive treatment option for chronic illness management.

2 min read

Georgia Tech researchers have developed a groundbreaking oral capsule capable of delivering insulin and other injectable medications without the need for injections. This innovative pill harnesses a simple chemical reaction of water and sodium bicarbonate to create internal pressure, causing the capsule to explode and release its medication directly into the small intestine. Unlike complex mechanical devices, this capsule contains no moving parts, batteries, or stored energy, making it inexpensive and easy to produce at scale.

The capsule is built from gelatin, similar to conventional pills, but is designed to withstand the harsh environment of the stomach thanks to ultraviolet light treatment. Once swallowed, the sodium bicarbonate reacts with gastric fluids, generating a rapid puff of high-velocity drug particles. This jet of medicine effectively bypasses the intestinal mucus barrier, allowing for efficient absorption into the bloodstream while protecting the drug from digestive enzymes.

This technology is particularly promising for protein-based drugs like insulin, semaglutide (sold as Ozempic and Wegovy), antibodies, and growth hormones, which traditionally require injection due to poor oral bioavailability. Current oral formulations, such as Rybelsus, see less than 1% absorption, requiring higher drug doses and reducing efficiency. The new capsule aims to increase absorption rates, potentially lowering doses and cost.

Led by Professor Mark Prausnitz, the research team emphasizes the capsule’s simplicity and manufacturing compatibility. Typical animal studies demonstrate that this capsule can regulate blood sugar levels comparably to injected insulin, marking a significant step forward in non-invasive diabetes management. The team is now working to optimize drug absorption levels and extend this technology to other therapeutics.

Prausnitz’s prior work on skin microneedles inspired this gastrointestinal application, utilizing high-pressure jetting akin to needle-free injections. The capsule’s mechanism mimics a tiny explosive device, rapidly ejecting drugs into the intestinal tissue, overcoming barriers that limit oral drug delivery.

This innovative approach not only has the potential to replace painful injections but could revolutionize the administration of a broad range of biologics, offering a safer, more convenient, and accessible treatment option for millions worldwide.

Source: https://medicalxpress.com/news/2025-07-capsules-insulin-needle-sodium-bicarbonate.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Nuclear Migration in T Cells Enhances Infection Defense

New research uncovers how the migration of the T cell nucleus enhances immune responses by positioning to the immune synapse, enabling rapid production of molecular weapons against infections and cancer.

Link Between PFAS Chemicals and Increased Risk of Type 2 Diabetes

New research reveals that exposure to PFAS 'forever chemicals' is linked to a 31% higher risk of developing type 2 diabetes, highlighting the need for reduced environmental exposure to improve public health.

New ESC/EAS Guidelines Introduce Enhanced Strategies for Cardiovascular Risk Assessment and Lipid Management

The latest ESC/EAS guidelines introduce improved cardiovascular risk prediction tools and treatment strategies, including statins for high-risk groups, to enhance lipid management and prevent cardiovascular disease.

U.S. Court Ruling Permits West Virginia to Limit Access to Mifepristone

A federal appeals court permits West Virginia to restrict access to mifepristone, a key medication used in early pregnancy termination, raising questions about state authority and federal regulation in healthcare.